Physical Symptoms of Opioid Withdrawal

Key Takeaways

• Opioid withdrawal produces a wide range of physical symptoms driven by autonomic nervous system rebound after opioids are removed.
• Cardiovascular changes including elevated heart rate and blood pressure are common and are monitored using the Clinical Opiate Withdrawal Scale (COWS).
• Gastrointestinal symptoms — nausea, vomiting, diarrhea — create the most significant medical risk through dehydration and electrolyte imbalance.
• Pain amplification (hyperalgesia), rhinorrhea, lacrimation, and piloerection are characteristic withdrawal features.
• Vivid dreams, blurry vision, and restless legs are less commonly discussed but frequently reported neurological effects.
• Medical detox with buprenorphine (Suboxone/Sublocade) or clonidine significantly reduces physical symptom severity.

Opioid withdrawal is an intensely physical experience. While psychological symptoms like anxiety and cravings receive considerable attention, the body-wide physiological effects of withdrawal are what drive most people to seek medical help or, in many cases, to return to opioid use simply to end the discomfort. Understanding the specific physical symptoms, why they occur, and how they are monitored allows individuals and families to make informed decisions about medical detox.

This page examines the physical symptoms of opioid withdrawal in detail, covering the underlying mechanisms and clinical significance of each symptom category.

How Opioid Withdrawal Affects the Body

The Autonomic Nervous System Rebound

Opioids suppress the sympathetic nervous system — the body’s stress response network. With chronic use, the body compensates by increasing sympathetic activity to maintain homeostasis. When opioids are abruptly removed, this compensatory upregulation is suddenly unopposed, producing a surge of sympathetic nervous system activity.

This autonomic rebound is responsible for many of the hallmark physical symptoms: rapid heart rate, elevated blood pressure, sweating, goosebumps, dilated pupils, and GI hypermotility. The locus coeruleus, a brainstem region rich in noradrenergic neurons, plays a central role in this process. During opioid use, activity in the locus coeruleus is suppressed. During withdrawal, it fires excessively, flooding the body with norepinephrine.

This mechanism explains why clonidine — an alpha-2 adrenergic agonist that dampens locus coeruleus activity — is effective at reducing many physical withdrawal symptoms.

Why Symptoms Vary by Person

No two withdrawal experiences are identical. The severity and duration of physical symptoms depend on several factors:

• Duration and amount of opioid use — longer and heavier use generally produces more severe withdrawal
• Type of opioid — short-acting opioids like heroin and fentanyl tend to produce more acute symptoms; long-acting opioids like methadone (Dolophine/Methadose) produce a prolonged but sometimes less intense course
• Individual metabolism and genetics — variations in liver enzyme activity and opioid receptor density affect withdrawal presentation
• Overall health status — chronic medical conditions, nutritional status, and age all influence symptom severity
• History of prior withdrawals — a phenomenon known as kindling may cause successive withdrawal episodes to become progressively more severe

Cardiovascular and Vital Sign Changes

Elevated Heart Rate and Blood Pressure

Tachycardia (elevated heart rate) and hypertension (elevated blood pressure) are among the most clinically significant physical symptoms of opioid withdrawal. Heart rate may increase by 20 to 40 beats per minute above the individual’s normal resting rate. Blood pressure elevations are typically modest but can be pronounced in individuals with pre-existing cardiovascular conditions.

These changes reflect the sympathetic nervous system surge described above. While generally not dangerous in healthy individuals, they warrant clinical monitoring because:

• Individuals with coronary artery disease, heart failure, or arrhythmias face increased cardiac risk during withdrawal
• Sustained tachycardia increases myocardial oxygen demand
• Hypertensive episodes, though usually self-limiting, can occasionally trigger complications

Temperature dysregulation is another common vital sign change. Individuals may alternate between feeling feverishly hot and experiencing chills, with actual body temperature sometimes mildly elevated.

Monitoring Vital Signs During Detox

In clinical detox settings, vital signs are typically monitored every 4 to 8 hours during the acute withdrawal period. The Clinical Opiate Withdrawal Scale (COWS) incorporates several vital sign measures — including resting pulse rate, sweating, and pupil dilation — to produce a standardized severity score.

COWS scoring guides clinical decision-making:

• A score of 5 to 12 indicates mild withdrawal
• A score of 13 to 24 indicates moderate withdrawal
• A score of 25 to 36 indicates moderately severe withdrawal
• A score above 36 indicates severe withdrawal

This assessment tool is particularly important when determining the appropriate timing for buprenorphine (Suboxone/Sublocade) induction, which generally should not begin until a patient is in at least moderate withdrawal to avoid precipitated withdrawal.

Gastrointestinal and Respiratory Symptoms

Nausea, Vomiting, and Diarrhea

GI symptoms are frequently cited as the most distressing physical aspect of opioid withdrawal. Opioids slow gastrointestinal motility — which is why constipation is a near-universal side effect of opioid use. During withdrawal, the GI tract rebounds with hypermotility, producing:

• Nausea and vomiting — can be severe, persistent, and debilitating during the peak withdrawal period (days 2 to 4 for short-acting opioids)
• Diarrhea — often watery and frequent, sometimes accompanied by severe abdominal cramping
• Loss of appetite — the combination of nausea and GI distress typically makes eating difficult

The medical significance of these symptoms cannot be understated. Uncontrolled vomiting and diarrhea create real risks:

• Dehydration — fluid losses can be substantial, particularly when oral rehydration is impossible due to ongoing vomiting
• Electrolyte imbalances — hypokalemia, hyponatremia, and metabolic alkalosis or acidosis can develop
• Aspiration risk — vomiting while in a weakened or semi-conscious state can lead to aspiration pneumonia

In the most severe cases, untreated dehydration during withdrawal has contributed to fatalities, particularly in correctional settings where medical monitoring may be inadequate.

Rhinorrhea and Lacrimation

Rhinorrhea (runny nose) and lacrimation (excessive tearing) are characteristic early withdrawal symptoms. They result from the same parasympathetic rebound that drives GI symptoms — secretory glands throughout the body become overactive once opioid suppression is removed.

These symptoms are generally not dangerous but are diagnostically significant. Clinicians use the presence of rhinorrhea and lacrimation as part of COWS assessment, and they often serve as the first visible indicators that withdrawal has begun.

Pain, Sleep Disruption, and Neurological Effects

Muscle and Bone Pain

Heightened pain sensitivity, or opioid-induced hyperalgesia, is one of the most challenging physical symptoms for people in withdrawal. Opioids suppress pain signaling; when they are removed, the nervous system overcorrects, amplifying pain well beyond baseline levels.

Individuals commonly report:

• Diffuse muscle aches — often described as deep, throbbing pain in the legs, back, and shoulders
• Joint pain — described as feeling similar to severe arthritis
• Bone pain — a sensation of aching deep within the bones, though the source is muscular and neurological rather than skeletal
• Generalized body sensitivity — even light touch or pressure can feel uncomfortable

This hyperalgesia typically resolves as the nervous system recalibrates over the first 1 to 2 weeks, though residual pain sensitivity can persist longer in individuals with prolonged opioid use histories.

Vivid Dreams and Insomnia

Sleep disruption is a nearly universal feature of opioid withdrawal and often persists well into the post-acute phase.

During the acute period, individuals experience:

• Insomnia — inability to fall asleep despite exhaustion, driven by autonomic hyperarousal and restlessness
• Restless legs syndrome — an irresistible urge to move the legs, worse at night, that severely impairs sleep onset
• Vivid and disturbing dreams — when sleep does occur, it is frequently disrupted by unusually intense, vivid, or nightmarish dreams

The neurological basis for vivid dreams during opioid withdrawal relates to REM sleep rebound. Opioids suppress REM sleep during active use. When opioids are removed, the brain compensates with excessive REM activity, producing abnormally vivid and emotionally charged dream content. This phenomenon parallels the REM rebound observed during alcohol withdrawal.

Sleep disturbances are a significant factor in relapse risk because chronic sleep deprivation impairs judgment, increases emotional reactivity, and amplifies drug cravings.

Vision Changes

Blurry vision during opioid withdrawal is less commonly discussed in clinical literature but is a well-documented patient complaint. The mechanism involves several factors:

• Pupil dilation (mydriasis) — dilated pupils allow more light to enter the eye, which can cause light sensitivity and difficulty focusing
• Autonomic instability — fluctuations in the autonomic nervous system affect the ciliary muscles that control lens shape
• Dehydration — reduced fluid status can affect tear film quality and visual clarity
• Fatigue — sustained exhaustion impairs visual accommodation

Vision changes are typically transient and resolve as the acute withdrawal phase subsides. However, they can be distressing, and individuals experiencing significant vision changes during withdrawal should have this evaluated to rule out other causes.

Managing Physical Symptoms Safely

Medical Detox vs. Going It Alone

The physical intensity of opioid withdrawal is the primary reason that medical detox is recommended over unassisted withdrawal. Medical detox does not simply make withdrawal more comfortable — it addresses genuine medical risks and dramatically improves the likelihood of completing the withdrawal process and transitioning to ongoing treatment.

Medications used to manage physical withdrawal symptoms include:

• Buprenorphine (Suboxone/Sublocade): Reduces virtually all withdrawal symptoms by partially activating opioid receptors. Considered the most effective single medication for withdrawal management.
• Clonidine: Targets the sympathetic rebound directly, reducing heart rate, blood pressure, sweating, and anxiety. Commonly used alongside other medications.
• Loperamide: An over-the-counter antidiarrheal that addresses GI symptoms without crossing the blood-brain barrier.
• Ondansetron and promethazine: Anti-nausea medications that help manage vomiting.
• Tizanidine or cyclobenzaprine: Muscle relaxants that address musculoskeletal pain.
• Hydroxyzine or trazodone: Used for anxiety and insomnia management.

When to Go to the Emergency Room

Most opioid withdrawal can be managed in outpatient or residential detox settings. Emergency room evaluation is warranted when:

• Persistent vomiting prevents any oral fluid intake for more than 12 hours
• Signs of severe dehydration develop: dark urine, dizziness, confusion, rapid heart rate at rest
• Withdrawal occurs alongside benzodiazepine or alcohol dependence, creating seizure risk
• The individual is pregnant — opioid withdrawal during pregnancy requires immediate medical management
• Chest pain, irregular heartbeat, or severe hypertension develop
• Suicidal thoughts or severe psychiatric symptoms emerge

New Jersey emergency departments are required to screen for substance use disorder and provide referrals to treatment. The state’s NJ CARES initiative facilitates warm handoffs from emergency departments to treatment providers.

---

This article is part of our complete guide to opioid addiction in New Jersey. For a timeline of withdrawal phases, see opioid withdrawal symptoms timeline. For information on treatment medications, visit opioid withdrawal medications and treatment.

For information on medical detox programs in New Jersey, see our resource on medical detox.